Generic Drug Labeling: A Report on Serious Warnings Added to Approved Drugs and on Generic Drugs Marketed Without a Brand-Name Equivalent
June 20, 2013
View as PDF.
View press release
Today, the majority of prescriptions filled in the United States are filled with generic drugs, making prescription drugs more affordable for patients. Many potential hazards are not discovered until years after drugs have been on the market, yet under current FDA regulations, generic drug manufacturers can do little to warn doctors and patients about newly discovered information, putting patients at risk. In this report, Public Citizen lists 53 drugs approved by the Food and Drug Administration more than 10 years ago that have required new black-box warnings over the past five years and also provides a list of more than 400 drugs for which the brand-name product is no longer sold.